BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20016468)

  • 1. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease.
    Galitzer H; Ben-Dov IZ; Silver J; Naveh-Many T
    Kidney Int; 2010 Feb; 77(3):211-8. PubMed ID: 20016468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.
    Komaba H; Goto S; Fujii H; Hamada Y; Kobayashi A; Shibuya K; Tominaga Y; Otsuki N; Nibu K; Nakagawa K; Tsugawa N; Okano T; Kitazawa R; Fukagawa M; Kita T
    Kidney Int; 2010 Feb; 77(3):232-8. PubMed ID: 19890272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
    Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
    Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF23-parathyroid interaction: implications in chronic kidney disease.
    Komaba H; Fukagawa M
    Kidney Int; 2010 Feb; 77(4):292-8. PubMed ID: 20010546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation?
    Drüeke TB
    Kidney Int; 2010 Dec; 78(11):1057-60. PubMed ID: 21076444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
    Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
    Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].
    Komaba H
    Clin Calcium; 2010 Jul; 20(7):1028-36. PubMed ID: 20585181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased parathyroid expression of klotho in uremic rats.
    Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
    Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia.
    Hassan A; Durlacher K; Silver J; Naveh-Many T; Levi R
    Am J Physiol Renal Physiol; 2016 Feb; 310(3):F217-21. PubMed ID: 26311115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
    Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF23 and the parathyroid.
    Silver J; Naveh-Many T
    Adv Exp Med Biol; 2012; 728():92-9. PubMed ID: 22396164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients?
    Lafage-Proust MH
    Kidney Int; 2010 Mar; 77(5):390-2. PubMed ID: 20150940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion.
    Galitzer H; Ben-Dov I; Lavi-Moshayoff V; Naveh-Many T; Silver J
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):363-7. PubMed ID: 18660671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF23 and the parathyroid glands.
    Silver J; Naveh-Many T
    Pediatr Nephrol; 2010 Nov; 25(11):2241-5. PubMed ID: 20526631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF23 fails to inhibit uremic parathyroid glands.
    Canalejo R; Canalejo A; Martinez-Moreno JM; Rodriguez-Ortiz ME; Estepa JC; Mendoza FJ; Munoz-Castaneda JR; Shalhoub V; Almaden Y; Rodriguez M
    J Am Soc Nephrol; 2010 Jul; 21(7):1125-35. PubMed ID: 20431039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.
    Krajisnik T; Björklund P; Marsell R; Ljunggren O; Akerström G; Jonsson KB; Westin G; Larsson TE
    J Endocrinol; 2007 Oct; 195(1):125-31. PubMed ID: 17911404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.
    Kumata C; Mizobuchi M; Ogata H; Koiwa F; Nakazawa A; Kondo F; Kadokura Y; Kinugasa E; Akizawa T
    Am J Nephrol; 2010; 31(3):230-8. PubMed ID: 20068287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The parathyroid is a target organ for FGF23 in rats.
    Ben-Dov IZ; Galitzer H; Lavi-Moshayoff V; Goetz R; Kuro-o M; Mohammadi M; Sirkis R; Naveh-Many T; Silver J
    J Clin Invest; 2007 Dec; 117(12):4003-8. PubMed ID: 17992255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.